Aethlon Medical, Inc. (AEMD)
1.48
-0.06
(-3.90%)
USD |
NASDAQ |
Sep 15, 16:00
1.49
+0.01
(+0.68%)
After-Hours: 20:00
Aethlon Medical Cash from Operations (TTM) : -7.18M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.18M |
| March 31, 2026 | -6.998M |
| December 31, 2025 | -6.921M |
| September 30, 2025 | -7.057M |
| June 30, 2025 | -7.613M |
| March 31, 2025 | -7.646M |
| December 31, 2024 | -8.538M |
| September 30, 2024 | -8.905M |
| June 30, 2024 | -9.395M |
| March 31, 2024 | -10.13M |
| December 31, 2023 | -10.51M |
| September 30, 2023 | -10.08M |
| June 30, 2023 | -10.26M |
| March 31, 2023 | -10.51M |
| December 31, 2022 | -10.66M |
| September 30, 2022 | -11.42M |
| June 30, 2022 | -10.42M |
| March 31, 2022 | -9.767M |
| December 31, 2021 | -8.907M |
| September 30, 2021 | -8.386M |
| June 30, 2021 | -7.735M |
| March 31, 2021 | -6.765M |
| December 31, 2020 | -6.147M |
| September 30, 2020 | -5.206M |
| June 30, 2020 | -5.052M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.198M |
| December 31, 2019 | -4.975M |
| September 30, 2019 | -4.805M |
| June 30, 2019 | -4.723M |
| March 31, 2019 | -4.293M |
| December 31, 2018 | -3.914M |
| September 30, 2018 | -3.617M |
| June 30, 2018 | -3.654M |
| March 31, 2018 | -3.911M |
| December 31, 2017 | -3.847M |
| September 30, 2017 | -3.845M |
| June 30, 2017 | -3.752M |
| March 31, 2017 | -3.506M |
| December 31, 2016 | -3.679M |
| September 30, 2016 | -3.855M |
| June 30, 2016 | -4.359M |
| March 31, 2016 | -4.329M |
| December 31, 2015 | -5.100M |
| September 30, 2015 | -5.893M |
| June 30, 2015 | -5.084M |
| March 31, 2015 | -5.049M |
| December 31, 2014 | -3.707M |
| September 30, 2014 | -2.789M |
| June 30, 2014 | -2.681M |
| March 31, 2014 | -2.139M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 56.52M |
| AtriCure, Inc. | 64.94M |
| Baxter International, Inc. | 1.319B |